等待开盘 10-31 09:30:00 美东时间
-0.080
-0.95%
 华盛通
华盛通WALTHAM, MA and BOULDER, CO — Cogent Biosciences announced updated preclinical data for its pan KRAS(ON) inhibitor at the 2025 AACR-NCI-EORTC conference. The lead molecule, CGT1263, shows best-in-class potential with potent activity against KRAS mutant cancers and selectivity over HRAS and NRAS. The company plans to file an IND in 2026.
10-24 16:30
Cognyte Software Ltd. (NASDAQ:CGNT) ("Cognyte"), a global leader in software-driven technology for investigative analytics, today announced a follow-on agreement valued at over $5 million with a long-standing military
10-22 20:04
Libero Copper & Gold ( ($TSE:CGNT) ) just unveiled an announcement. Copper ...
10-15 20:21
Cognyte Software (NASDAQ: NASDAQ:CGNT) announced a follow-on contract valued at over $5M with a tier-1 military organization in the Europe-Middle East-Africa region. The company has finalized an annu...
10-08 21:45
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从15美元升至18美元;Ascendiant Capital:维持Surgepays"买入"评级,目标价从9美元升至9.5美元
10-06 08:35
Roth Capital analyst Taz Koujalgi initiates coverage on Cognyte Software (NASDAQ:CGNT) with a Buy rating and announces Price Target of $14.
10-04 02:01
Cognyte Software shares are trading higher after the company announced a one-ye...
09-25 04:03
Cognyte Software Ltd. (($CGNT)) has held its Q2 earnings call. Read on for the ...
09-10 08:03
Cognyte Software shares are trading lower. The company reported Q2 financial re...
09-09 23:13
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is projected t...
09-09 16:32